Literature DB >> 29801742

Elevated Incidence of Atrial Fibrillation and Stroke in Patients With Atrial Flutter-A Population-Based Study.

Lorne J Gula1, Damian P Redfearn2, Krista B Jenkyn3, Britney Allen3, Allan C Skanes4, Peter Leong-Sit4, Salimah Z Shariff3.   

Abstract

BACKGROUND: The risk of stroke from atrial flutter and its relationship with progression to atrial fibrillation (AF) is unclear. This study describes the incidence of AF and stroke in patients with atrial flutter, and whether atrial flutter ablation attenuates the incidence of AF and stroke.
METHODS: We performed a population-based retrospective cohort study of adults with typical atrial flutter with no AF history. Using linked health administrative databases we defined 3 cohorts: (1) adult patients diagnosed with new isolated atrial flutter; (2) a contemporary, 1-to-1 matched cohort from the Ontario population; and (3) patients with isolated atrial flutter who underwent atrial flutter ablation.
RESULTS: A total of 9339 new typical atrial flutter patients were identified and 7248 were matched to general population subjects. Over the 3-year follow-up, AF occurred in 40.4% of patients with atrial flutter, and 3.3% of the matched general population (rate ratio, 12.2; P < 0.001). Stroke occurred in 4.1% of patients with atrial flutter and 1.2% of the general population cohort (rate ratio, 3.4; P < 0.001). Among 218 patients who had an atrial flutter ablation, AF occurred in 47 (21.6%) over the following 3 years, and incidence of stroke was between 0 and 2.3%.
CONCLUSIONS: Patients with isolated atrial flutter develop AF and stroke at a higher rate than the general population. Catheter ablation reduces but does not eliminate future AF incidence and stroke risk and continued anticoagulation after successful atrial flutter ablation might therefore be warranted.
Copyright © 2018 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29801742     DOI: 10.1016/j.cjca.2018.01.001

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  3 in total

1.  Anesthetic management using remimazolam in a patient with atrial flutter: a case report.

Authors:  Joo Yong Lee; Hyeon Tae Kim; Yae Jee Kim; Jin Sol Lee; Jin Wook Park; Young Duck Shin
Journal:  Am J Transl Res       Date:  2022-08-15       Impact factor: 3.940

2.  Cerebrovascular accidents differ between patients with atrial flutter and patients with atrial fibrillation.

Authors:  Jacek Staszewski; Anna Bilbin-Bukowska; Wojciech Szypowski; Marcin Mejer-Zahorowski; Adam Stępień
Journal:  Arch Med Sci       Date:  2019-07-18       Impact factor: 3.318

Review 3.  Heart failure and atrial flutter: a systematic review of current knowledge and practices.

Authors:  Michael J Diamant; Jason G Andrade; Sean A Virani; Pardeep S Jhund; Mark C Petrie; Nathaniel M Hawkins
Journal:  ESC Heart Fail       Date:  2021-09-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.